Therapeutic antibodies designed to block or activate immune checkpoint receptors are a powerful new approach to the treatment of cancer and other diseases. However, due to their biologic complexity the development of therapeutic antibodies requires unique functional and analytical tools. This webinar highlights the a suite of MOA-based functional bioassays for use in antibody screening, characterization, potency testing and stability studies.
Richard Somberg, PhD
Strategic Collaborations Manager
We love to talk science.
Sign up to receive monthly invitations to our webinars.